Matthew Vanneman

Oncology · 2012

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Matthew Vanneman trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Stephen W. Fesik
  2. N. Ferrara
  3. S. Grivennikov
  4. Gabriel A. Rabinovich

Who trusts Matthew Vanneman overall

  1. Daniel S. Chen

Papers from Matthew Vanneman's perspective

Ordered by how strongly the researchers Matthew Vanneman trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Immunosuppressive strategies that are mediated by tumor cells. (Annual Review of Immunology)
  2. Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria (Clinical Cancer Research)
  3. Promoting apoptosis as a strategy for cancer drug discovery (Nature Reviews. Cancer)
  4. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. (Molecules and Cells)
  5. PD-1 and its ligands in tolerance and immunity. (Annual Review of Immunology)
  6. Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive immunotherapy of cancer (Cancer Research)
  7. The B7 family revisited. (Annual Review of Immunology)
  8. Angiogenesis as a therapeutic target (Nature)
  9. Selective BRAFV600E inhibition enhances T-cell recognition of melanoma without affecting lymphocyte function. (Cancer Research)
  10. Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large… (Blood)

Their papers